Journals / Akdeniz Tıp Dergisi / 2022 / Cilt: 8 - Sayı: 1

Evaluation of Prognostic Factors in Patients with COVID-19: Ankara City Hospital Experience as a Pandemic Center

COVID-19’lu Hastalardaki Prognostik Faktörlerin Değerlendirilmesi: Pandemik Bir Merkez Olan Ankara Şehir Hastanesi Deneyimi

Pages
9–15
Publication Date
2022-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Key Words: COVID-19, SARS-CoV-2, Lymphopenia, Interleukin-6, Univariate analysis, Multivariate analysis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Objective: Aim of the study was to analyze systematically the basic clinical characteristics and laboratory indexes in patients with COVID-19 followed in clinical service and intensive care, and to predict the possible course of the disease in the early period.
📊
Key Findings & Data:Methods: This retrospective, single-center study was conducted between April 1 and May 31, 2020 at Ankara City Hospital.
💡
Conclusion & Impact:Key Words: COVID-19, SARS-CoV-2, Lymphopenia, Interleukin-6, Univariate analysis, Multivariate analysis
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:COVID-19 · SARS-CoV-2 · Lenfopeni

Abstract

ABSTRACT Objective: Aim of the study was to analyze systematically the basic clinical characteristics and laboratory indexes in patients with COVID-19 followed in clinical service and intensive care, and to predict the possible course of the disease in the early period. Methods: This retrospective, single-center study was conducted between April 1 and May 31, 2020 at Ankara City Hospital. The patients were divided into two groups: one received ordinary care, the other intensive therapy, and the clinical data were compared between the two groups.Univariate and multivariate logistic regression analysis were performed to identify independent early predictors for COVID-19 patients in intensive care. ROC analysis was performed to determine whether interleukin-6 has a diagnostic value in predicting hospitalization in intensive care. Results: Multivariable logistic regression analysis found that increasing age (adjusted odds ratio [OR], 1,1; 95% confidence interval [CI]; 1,06-1,14; p19,85 pg/ml. Conclusion: Progression is more advanced in patients with early COVID-19 with increasing age, lymphopenia and high interleukin 6 levels, and these patients are mostly followed in intensive care.If a patient has one of these three criteria, surveillance of the disease process and intensive care priority increases. Early identification of critical patients will make things easier in tackling the COVID-19 outbreak. Key Words: COVID-19, SARS-CoV-2, Lymphopenia, Interleukin-6, Univariate analysis, Multivariate analysis

Özet

ÖZ Amaç: Klinik serviste ve yoğun bakımda takip edilen COVID-19’lu hastalarda temel klinik karakteristikler ve laboratuvar indekslerini sistematik olarak analiz ederek erken dönemde hastalığın olası seyri hakkında ön görüde bulunabilmek amaçlandı. Gereç ve Yöntemler: Bu retrospektif, tek merkezli çalışma 1 Nisan ile 31 Mayıs 2020 tarihleri arasında Ankara Şehir Hastanesi'nde gerçekleştirilmiştir. Hastalar serviste ve yoğun bakımda takip edilen olmak üzere ikiye ayrıldı ve klinik veriler iki grup arasında karşılaştırıldı. Yoğun bakımdaki COVID-19 hastaları için bağımsız erken prediktörleri tanımlamak için tek değişkenli ve çok değişkenli lojistik regresyon analizi yapıldı. İnterlökin-6’nın yoğun bakımda yatışı öngörmesinde tanısal değerinin olup olmadığının belirlenebilmesi için ROC analizi yapıldı. Bulgular: Çok değişkenli lojistik regresyon analizine göre artan yaş (Odds oranı [OR] 1,1;%95 güven aralığı [GA] 1,06–1,14; p19,85 pg/ml olarak tespit edildi. Sonuç: İleri yaş, lenfopeni ve yüksek interlökin 6 düzeyleri olan erken COVID-19’lu hastalarda progresyon daha ileri olup bu hastalar daha çok yoğun bakımda izlenmektedir. Eğer bir hasta bu üç kriterden birine sahipse hastalık sürecinin sürveyansı ve yoğun bakım önceliği artmaktadır. Kritik hastaların erken tespiti, COVID-19 salgınıyla mücadelede işleri kolaylaştıracaktır. Anahtar Sözcükler: COVID-19, SARS-CoV-2, Lenfopeni, İnterlökin-6, Tek değişkenli analiz, Çok değişkenli analiz

🔖

Cite This Article

SALMAN, E., ÇELİKBİLEK, N., ÖZDEM, B., GÖKAY, S., AYDOĞAN, S., KIRCA, F., TOYRAN, A., SALMAN, R. B., DİNÇ, B. (2022). Evaluation of Prognostic Factors in Patients with COVID-19: Ankara City Hospital Experience as a Pandemic Center. Akdeniz Tıp Dergisi, Cilt: 8 - Sayı: 1, 9–15. https://ajindex.com/articles/725645

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011; 81: 85-164
  2. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-6
  3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020; 395: 565-74
  4. Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, Lang C, Xiao Q, Xiao K, Yi Z, Qiang M, Xiang J, Zhang B, Chen Y. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv, 2020
  5. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nature reviews Immunology 2014; 14: 36-49
  6. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J. Coronavirus infections and immune responses. J Med Virol 2020; 92: 424-32
  7. George, M R. Hemophagocytic lymphohistiocytosis: review of etiologies and management. Journal of blood medicine 2014; 5: 69
  8. Meduri, G., Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome.Chest 1995; 8: 1303-14
  9. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020; 395: 507-13
  10. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382: 1708-20
  11. Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, Ge L, Wang F, Chen Q, Zhang Y, Zhao Q. Clinical c